Pulse Biosciences, Inc (PLSE): Price and Financial Metrics
GET POWR RATINGS... FREE!
PLSE Stock Price Chart Interactive Chart >
PLSE Price/Volume Stats
|Current price||$1.52||52-week high||$29.16|
|Prev. close||$1.53||52-week low||$1.41|
|Day high||$1.61||Avg. volume||215,606|
|50-day MA||$2.21||Dividend yield||N/A|
|200-day MA||$10.89||Market Cap||45.30M|
Pulse Biosciences, Inc (PLSE) Company Bio
Pulse Biosciences, a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was founded in 2014 and is based in Burlingame, California.
Most Popular Stories View All
PLSE Latest News Stream
|Loading, please wait...|
PLSE Latest Social Stream
View Full PLSE Social Stream
Latest PLSE News From Around the Web
Below are the latest news stories about Pulse Biosciences Inc that investors may wish to consider to help them evaluate PLSE as an investment opportunity.
DEADLINE: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE
SAN DIEGO, Feb. 19, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Pulse Biosciences, Inc. (NASDAQ: PLSE) securities between January 12, 2021 and February 7, 2022, inclusive (the "Class Period") have until April 18, 2022 to seek
Shareholder Alert: Robbins LLP Informs Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders
SAN DIEGO--(BUSINESS WIRE)---- $PLSE #attorney--Pulse Biosciences, Inc. (PLSE) Misstated the Viability of its CellFX System for Treating Sebaceous Hyperplasia Lesions
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)---- $PLSE #PLSE--The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLSE
NEW YORK--(BUSINESS WIRE)---- $PLSE #PLSE--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 through February 7, 2022, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 18, 2022. SO WHAT: If you purchased Pulse securities during the Class P
ALERT: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE
SAN DIEGO--(BUSINESS WIRE)-- #PLSEstock--The suit alleges defendants issued false statements re: Pulse Biosciences business & prospects, resulting in its stock trading at inflated prices.
PLSE Price Returns